- TWD7.44bn
- TWD9.85bn
- TWD9.18bn
- 89
- 67
- 62
- 89
R2019 December 31st | 2020 December 31st | C2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,032 | 8,350 | 13,312 | 10,992 | 9,184 |
Cost of Revenue | |||||
Gross Profit | 1,994 | 2,109 | 2,542 | 2,742 | 2,435 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,243 | 7,701 | 12,786 | 10,152 | 8,639 |
Operating Profit | 789 | 648 | 527 | 840 | 545 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 788 | 614 | 986 | 864 | 507 |
Provision for Income Taxes | |||||
Net Income After Taxes | 623 | 478 | 784 | 676 | 367 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 630 | 405 | 616 | 528 | 362 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 630 | 405 | 616 | 528 | 362 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.42 | 3.51 | 2.12 | 5.26 | 3.28 |
Dividends per Share |